22 September 2022 : Clinical Research
Impact of Adherence with Disease-Modifying Therapies on All-Cause Mortality Rates Among Veterans with Multiple Sclerosis
Meheroz H. Rabadi12ABCDEF*, Kimberly Just1B, Chao Xu
3CDE
DOI: 10.12659/MSM.938116
Med Sci Monit 2022; 28:e938116
Table 2 Comparison of mortality in groups defined by adherence to adherence to disease-modifying therapies.
| Survival | Overall (n=279) | Non-adherent (n=148) | Poor-adherence (n=13) | Good-adherence (n=118) | P-value | ||
|---|---|---|---|---|---|---|---|
| Non vs poor | None vs good | Good vs poor | |||||
| Alive | 223 (79.9%) | 99 (66.9%) | 12 (92.3%) | 112 (94.9%) | 0.066 | <0.001 | 0.528 |
| Dead | 56 (20.1%) | 49 (33.1%) | 1 (7.7%) | 6 (5.1%) | |||